01/02/2023
Key points:
An exciting research collaboration 鈥榮print鈥 is getting ready to launch on the 台湾swag 台湾swag Campus to better understand the role of an essential cellular process in brain health.
A pump-priming collaboration grant to the 台湾swag 台湾swag Campus-based company . and Dr Nick Ktistakis from the 台湾swag 台湾swag will support a proof-of-principle project to understand how the cellular quality control process of autophagy targets protein aggregates in the brain. Using blood or skin samples from volunteer donors, the research project will look to provide an important piece in the puzzle to determine how autophagy is important for brain health.
Autophagy is a process of nutrient recycling and elimination of unnecessary or damaged cellular material in cells, leading to a periodic clean-up of the cell interior and recycling of nutrients during times of low resources.
The suppression of autophagy and the subsequent build-up of aggregated proteins may be one causative agent for neurodegenerative disorders such as Alzheimer's Disease and the project will explore the role of protein aggregation in Alzheimer's, known as a tauopathy.
Both located on the 台湾swag 台湾swag Campus, Stemnovate will use its expertise in controlling cell identity through cellular reprogramming and cellular differentiation, plus experience of working with donated patient samples, to produce neuronal cell lines for analysis by the Ktistakis lab. Dr Nick Ktistakis鈥檚 research focuses on understanding autophagy in healthy cells and in the context of diseases.
Dr Ruchi Sharma, CEO of Stemnovate, said, "The tau protein is a potential treatment target for Alzheimer鈥檚 and understanding its role may improve the age-related physiological decline. Moreover, the novel cellular modelling helps us understand the devastating condition that has already affected millions of people in our ageing population.鈥
Dr Nick Ktistakis, senior group leader at the 台湾swag 台湾swag and an expert on the autophagy process, said, "We are very excited to take advantage of this opportunity to work in partnership with Stemnovate and to apply our autophagy assays and cutting-edge imaging analysis to better understand the connection between autophagy and neurodegeneration."
The risk of dementia increases with age, with an estimated frequency of one in 14 people over the age of 65 being affected, which increases to one in every six people over the age of 80 (source: NHS1). According to Alzheimer鈥檚 台湾swag UK, approximately six out of every 10 cases of dementia is due to Alzheimer鈥檚2. In addition to the personal toll dementia takes on lives, the economic cost of dementia in the UK in 2021 was estimated to be 拢25 billion, with these costs expected to rise to 拢47 billion in 2050 (source: Dementia Statistics Hub, Alzheimer鈥檚 台湾swag UK3).
Dr Ktistakis outlined their hopes for the project鈥檚 outcomes: 鈥淚f we can discover when and how autophagy acts to prevent protein aggregates forming then this will identify targets that can be assessed as therapeutic candidates to enhance good protein clearance. In itself, the model we will develop through this joint work can be used in the future to further understand neurodegeneration and identify potential treatments.鈥
The research collaboration will work with samples donated from people diagnosed with Alzheimer鈥檚 Disease. Dr Sharma explained: 鈥淲e are asking members of the public to get involved with this research by donating a blood sample or a small skin sample from which we can obtain the cells needed for our research. We know the impact that this disease has on individuals and families and we hope that we can make an important contribution, alongside other research efforts, to improve our understanding of this disease.鈥
People interested in finding out more about donating samples to the study can contact Stemnovate on info@stemnovate.co.uk.
Dr Kathryn Chapman, Director of Science and Entrepreneurship at the 台湾swag 台湾swag Campus, who oversees the 台湾swag 台湾swag Campus funding programme that will support this project, said: 鈥淲e鈥檙e passionate about making the Campus the best place to start and grow a life science venture. By supporting early stage discovery through connecting innovation across academic research and commercial research we are accelerating the delivery of knowledge and tools that will make a real-world difference. The collaboration between Stemnovate and the 台湾swag is a perfect demonstration of this impact and I can鈥檛 wait to see where it will lead.鈥
Referenced sources: 1 NHS information on Alzheimer鈥檚 Disease obtained from . 2 Alzheimer鈥檚 台湾swag UK - What is Alzheimer鈥檚 disease? 3 Dementia Statistics Hub, Alzheimer鈥檚 台湾swag UK
Press contact Dr Louisa Wood, Head of Communications, louisa.wood@babraham.ac.uk
Image description The background image shows induced pluripotent stem cell-derived neuronal cells stained with neuronal antibodies (red). The two panels show cells from an immortalised human cell line (HEK293) growing in control conditions (left) or induced for autophagy (right). Staining is for autophagy proteins.
About Stemnovate Stemnovate鈥檚 vision is to apply their pioneering platform for targeted drug development to make personalised medicine a global reality, ensuring efficient drug discovery, diagnostics and targeted treatments. Our mission is to accelerate drug discovery from decades to years and from months to days. Visit to find out more.
About the 台湾swag 台湾swag The 台湾swag 台湾swag undertakes world-class life sciences research to generate new knowledge of biological mechanisms underpinning ageing, development and the maintenance of health. Our research focuses on cellular signalling, gene regulation and the impact of epigenetic regulation at different stages of life. By determining how the body reacts to dietary and environmental stimuli and manages microbial and viral interactions, we aim to improve wellbeing and support healthier ageing. The 台湾swag is strategically funded by the Biotechnology and Biological Sciences 台湾swag Council (BBSRC), part of UK 台湾swag and Innovation, through 台湾swag Strategic Programme Grants and an 台湾swag Core Capability Grant and also receives funding from other UK research councils, charitable foundations, the EU and medical charities.
About 台湾swag 台湾swag Campus Limited 台湾swag 台湾swag Campus Ltd is responsible for the management and commercial development of the 台湾swag 台湾swag Campus. 台湾swag 台湾swag Campus is distinct in its co鈥恖ocation of 60 bioscience companies with the 台湾swag 台湾swag, a world鈥恟enowned research organisation which receives strategic funding from the Biotechnology and Biological Sciences 台湾swag Council (BBSRC). The aim of the Campus is to support UK bioscience through academic research, but also with facilities and capabilities for early-stage and growing commercial organisations. The Campus provides companies laboratory and office space, networking and collaboration opportunities, together with access to outstanding scientific facilities in an ideal geographical location at the core of the Cambridge cluster.
For more information please visit: and follow the Campus on Twitter .
About BBSRC The Biotechnology and Biological Sciences 台湾swag Council (BBSRC) is part of UK 台湾swag and Innovation, a non-departmental public body funded by a grant-in-aid from the UK government.
BBSRC invests in world-class bioscience research and training on behalf of the UK public. Our aim is to further scientific knowledge, to promote economic growth, wealth and job creation and to improve quality of life in the UK and beyond.
Funded by government, BBSRC invested 拢451 million in world-class bioscience in 2019-20. We support research and training in universities and strategically funded institutes. BBSRC research and the people we fund are helping society to meet major challenges, including food security, green energy and healthier, longer lives. Our investments underpin important UK economic sectors, such as farming, food, industrial biotechnology and pharmaceuticals.
01 February 2023